Literature DB >> 34190903

Microbiological and molecular characterization of antimicrobial resistance in uropathogenic Escherichia coli from peruvian public hospitals.

Pool Marcos-Carbajal1,2, Guillermo Salvatierra2, José Yareta1, Jimena Pino3, Nancy Vásquez3, Pilar Diaz4, Isabel Martínez5, Percy Asmat6, Carlos Peralta7, Caridad Huamani7, Alexander Briones8, Manuel Ruiz9, Nicomedes Laura10, Álvaro Luque11, Leonel Arapa12, Pablo Tsukayama2.   

Abstract

We characterized the antimicrobial resistance of 70 Escherichia coli isolates obtained from patients with a urinary tract infection (UTI) from 8 public hospitals in Peru. Resistance profiles were identified using the automated MicroScan® system. A standard polymerase chain reaction was used for the detection of the bla TEM, bla CTX-M, bla SHV and bla PER genes. The 65.7% (46/70) of the isolates presented a multidrug-resistant phenotype and 55.7% (39/70) were extended-spectrum beta-lactamases producers. High levels of resistance were detected for ampicillin (77,1%), ciprofloxacin (74,3%), trimethoprim/sulfamethoxazole (62,9%), cefepime (57,1%), and cefuroxime (57,1%). The bla TEM gene was the most frequent (31,4%), followed by bla CTX-M (18,6%) and bla SHV (2,9%) genes. These results show high resistance levels to antimicrobials of clinical use in E. coli isolates from hospital UTI patients in Peru.

Entities:  

Year:  2021        PMID: 34190903     DOI: 10.17843/rpmesp.2021.381.6182

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  1 in total

1.  Molecular characterization of multiresistant enterobacteria in two departments of the Peruvian jungle

Authors:  Diana León-Luna; Alexander Fajardo-Loyola; José Yareta-Yareta; Antonio Burgos-Espejo; Carlos Peralta-Siesquen; Marco Galarza-Pérez; Pool Marcos-Carbajal
Journal:  Biomedica       Date:  2021-10-15       Impact factor: 0.935

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.